Pharmacodynamic study of chitosan in combination with salvianolic acid B in the treatment of CC14‐induced liver fibrosis in mice
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacodynamic study of chitosan in combination with salvianolic acid B in the treatment of CC14‐induced liver fibrosis in mice
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-09-26
DOI
10.1111/1440-1681.13828
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gut microbiota combined with metabolomics reveal the mechanism of curcumol on liver fibrosis in mice
- (2022) Yang Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease
- (2022) Jiayao Feng et al. Marine Drugs
- Ameliorative Effect of Chitosan Oligosaccharides on Hepatic Encephalopathy by Reshaping Gut Microbiota and Gut–Liver Axis
- (2022) Wei Qi et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR
- (2022) Rong Wang et al. PHYTOMEDICINE
- The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration
- (2021) Zhipeng Zheng et al. Frontiers in Immunology
- Chitosan-based nanoparticles against bacterial infections
- (2020) Somaye Rashki et al. CARBOHYDRATE POLYMERS
- Antimicrobial and antioxidant properties of chitosan and its derivatives and their applications: A review
- (2020) Mohamed E. Abd El-Hack et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-κB and MAPK Signaling Pathways
- (2019) Rui Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chitosan-based (Nano)materials for Novel Biomedical Applications
- (2019) Kravanja et al. MOLECULES
- The effect of lactobacillus cell size on its probiotic characteristics
- (2019) Shadi Rajab et al. ANAEROBE
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Sal B Alleviates Myocardial Ischemic Injury by Inhibiting TLR4 and the Priming Phase of NLRP3 Inflammasome
- (2019) Yang Hu et al. MOLECULES
- New concepts on the clinical course and stratification of compensated and decompensated cirrhosis
- (2017) Gennaro D’Amico et al. Hepatology International
- Preparation and anti-tumor metastasis of carboxymethyl chitosan
- (2015) Zhiwen Jiang et al. CARBOHYDRATE POLYMERS
- Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging
- (2015) Dan Li et al. EJNMMI Research
- Basic and clinical research on the regulation of the intestinal barrier by Lactobacillus and its active protein components: a review with experience of one center
- (2014) Zhi-Hua Liu et al. MOLECULAR BIOLOGY REPORTS
- Pathogenesis of liver cirrhosis
- (2014) Wen-Ce Zhou WORLD JOURNAL OF GASTROENTEROLOGY
- Chitosan as a barrier membrane material in periodontal tissue regeneration
- (2012) Chun Xu et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
- Nutrition and colonic health: the critical role of the microbiota
- (2009) Stephen JD OʼKeefe CURRENT OPINION IN GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started